Price$2.75+0.05 (+1.85%)
01:30 PM03:45 PM
News · 26 weeks84-67%
2026-04-122026-10-04
Mix5090d
- SEC Filings28(56%)
- Other12(24%)
- Insider7(14%)
- Leadership2(4%)
- Market1(2%)
Latest news
25 items- INSIDERSEC Form 3 filed by ASP Isotopes Inc.3 - ASP Isotopes Inc. (0001921865) (Reporting)
- SECSEC Form SCHEDULE 13D filed by ASP Isotopes Inc.SCHEDULE 13D - ASP Isotopes Inc. (0001921865) (Filed by)
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - ASP Isotopes Inc. (0001921865) (Filer)
- INSIDERDirector Ryan Robert John Andrew bought $40,200 worth of shares (15,000 units at $2.68), increasing direct ownership by 2% to 675,222 units (SEC Form 4)4 - ASP Isotopes Inc. (0001921865) (Issuer)
- INSIDERDirector Ryan Robert John Andrew bought $21,600 worth of shares (8,000 units at $2.70), increasing direct ownership by 1% to 660,222 units (SEC Form 4)4 - ASP Isotopes Inc. (0001921865) (Issuer)
- SECSEC Form 144 filed by ASP Isotopes Inc.144 - ASP Isotopes Inc. (0001921865) (Subject)
- INSIDERCOO Ainscow Robert sold $36,216 worth of shares (8,438 units at $4.29) as part of a pre-agreed trading plan, decreasing direct ownership by 0.37% to 2,248,441 units (SEC Form 4) (withholding tax)4 - ASP Isotopes Inc. (0001921865) (Issuer)
- SECSEC Form 425 filed by ASP Isotopes Inc.425 - ASP Isotopes Inc. (0001921865) (Filed by)
- SECSEC Form 425 filed by ASP Isotopes Inc.425 - ASP Isotopes Inc. (0001921865) (Filed by)
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ASP Isotopes Inc. (0001921865) (Filer)
- PRASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational UpdateDALLAS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for critical materials production, today hosts its inaugural Capital Markets Day in London. Management will outline the Company's strategy across nuclear medicine, electronics, helium and LNG, and nuclear fuels, and will provide an overview of the building blocks supporting the Company’s long-term growth potential. Over the past 12 months, the Company has moved from development into early commercialization across several of its businesses. At today's event, management intends to provide a summary of wha
- INSIDEREVP, Gen Counsel, Secretary Ainscow Donald George sold $92,107 worth of shares (23,678 units at $3.89), decreasing direct ownership by 3% to 776,322 units (SEC Form 4) to satisfy withholding obligation4 - ASP Isotopes Inc. (0001921865) (Issuer)
- INSIDERCOO Ainscow Robert sold $97,625 worth of shares (25,000 units at $3.90) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 2,256,879 units (SEC Form 4)4 - ASP Isotopes Inc. (0001921865) (Issuer)
- INSIDERChairman and CEO Mann Paul Elliot sold $999,237 worth of shares (251,275 units at $3.98) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 9,328,570 units (SEC Form 4) (withholding tax)4 - ASP Isotopes Inc. (0001921865) (Issuer)
- SECSEC Form 144 filed by ASP Isotopes Inc.144 - ASP Isotopes Inc. (0001921865) (Subject)
- SECSEC Form 425 filed by ASP Isotopes Inc.425 - ASP Isotopes Inc. (0001921865) (Filed by)
- SECASP Isotopes Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - ASP Isotopes Inc. (0001921865) (Filer)
- SECSEC Form 425 filed by ASP Isotopes Inc.425 - ASP Isotopes Inc. (0001921865) (Filed by)
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ASP Isotopes Inc. (0001921865) (Filer)
- PRASP Isotopes Inc. Announces that Renergen Limited’s Subsidiary has Commenced Commissioning of Liquid Helium Plant in South AfricaTetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has started the commissioning phase of the Phase 1 Liquid Helium plant post engineering optimization The production is expected to be among the first new liquid helium supply to enter the market at a time of acute global shortage The Company remains on track to deliver liquid helium to customers during September and ramp production to nameplate capacity during 2H Following the successful start-up of Phase 1, the Company expects to advance to Phase 2 during 2H 2026. The Company is currently exploring ways to accelerate the revenues and cash flows from Phase 2 DALLAS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- ASP Iso
- PRPresenting on Emerging Growth Conference 95 Day 2 on August 20; Register to live streamMIAMI, Aug. 19, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 95th Emerging Growth Conference on August 19 & 20, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter All times are in Eastern Time Presenting Today – Wednesday August 19, 2026 8:30Virtual Lobby opens.Register for the Con
- SECASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ASP Isotopes Inc. (0001921865) (Filer)
- PRASP Isotopes Announces Quantum Leap Energy is Evaluating Metal Conversion Opportunities in NamibiaDALLAS, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI") today announced that Quantum Leap Energy LLC ("we," "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, is evaluating metal conversion opportunities in Namibia. As part of this evaluation, a public environmental and social impact assessment and consultation process has commenced for a proposed pilot-scale hydrofluorination and fluorination facility in the Walvis Bay area of Namibia. The proposed facility would be used to develop, test and demonstrate hydrofluorination an
- PRPresenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live streamMIAMI, Aug. 18, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 95th Emerging Growth Conference on August 19 & 20, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com For updates, follow us on Twitter All times are in Eastern Time Day 1 - WednesdayAugust 19, 2026 8:30Virtual Lobby opens.Register for the Conference. I
- SECSEC Form 10-Q filed by ASP Isotopes Inc.10-Q - ASP Isotopes Inc. (0001921865) (Filer)
ASPI FAQ
6 questionsWhere does ASPI stock trade?
ASP Isotopes Inc. (ASPI) is listed on NASDAQ.What sector and industry is ASPI in?
ASP Isotopes Inc. operates in the Industrials sector, Major Chemicals industry.When did ASP Isotopes Inc. go public?
ASP Isotopes Inc. (ASPI) completed its IPO in 2022.What are analysts saying about ASPI?
ASP Isotopes Inc. has had 3 recent analyst actions on file. The most recent action was from Cantor Fitzgerald: Overweight with a $1300.00 price target on 2025-12-04. Recent price targets range from $325.00 to $1300.00.What companies are similar to ASPI?
Notable peers in the same industry include LIN (Linde plc), APD (Air Products and Chemicals Inc.), IFF (International Flavors & Fragrances Inc.), DOW (Dow Inc.), LYB (LyondellBasell Industries NV). Compare ASPI side-by-side with any of them on Quantisnow.How can I track ASPI on Quantisnow?
Quantisnow aggregates ASP Isotopes Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ASPI to receive live email and push alerts on every new disclosure.